Rizact 5 MD Tablet
By Rizact
Rx
2 Tablet MD in a Strip

Composition
Rizatriptan(5mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
August, 2025

liver
When using Rizact 5 MD Tablet, it is important to be cautious if you have liver disease. It may be necessary to adjust the dosage of the tablet for patients with liver issues. Consulting your doctor is crucial to ensure safe and effective use of Rizact 5 MD Tablet.

kidney
Rizact 5 MD Tablet should be used carefully in severe kidney disease. Adjusting the dose may be necessary, and consulting a doctor is advised. Not recommended for severe kidney disease.

alcohol
Caution is advised when alcohol is consumed with Rizact 5 MD Tablet. It is recommended to consult a doctor for further guidance.

driving
It is important not to drive when taking Rizact 5 MD Tablet because it can reduce alertness, impact vision, and cause drowsiness and dizziness. If you experience these symptoms, avoid driving.

pregnancy
Rizact 5 MD Tablet may not be safe during pregnancy. Animal studies indicate potential harm to the developing baby. Consult your doctor about the risks versus benefits before use.

breastfeeding
Rizact 5 MD Tablet appears safe for breastfeeding based on limited human data, indicating minimal risk to the baby.
Habit Forming | No |
Chemical Class | Tryptamines Derivative |
Therapeutic Class | - |
Action Class | Triptans (5HT 1B/1D Agonist) |
₹100
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024